The legislation which governed medical devices (MD) having largely demonstrated its ineffectiveness during the PIP implant scandal, the new European regulation EU 2017/745 strengthens patient safety by establishing a clinical evaluation of the MD, monitoring after placement on the market. market and introducing a unique identification system for better traceability and greater transparency.
Stéphane ANCEL, Sales Director at Ackomas, presents the Ackomas approach and its ACKOMAS solution in an exclusive interview with The Pharmaceutical Post magazine.
Stéphane ANCEL, Sales Director at Ackomas, presents the Ackomas approach and its ACKOMAS solution in an exclusive interview with The Pharmaceutical Post magazine.
Two possibilities to access the entire interview (P62):
- Download the complete file
- Immediate online access
Good reading !
